Is Merck KGaA (MKKGY) Stock Undervalued Right Now?

27.11.24 15:40 Uhr

Werte in diesem Artikel
Aktien

97,30 EUR 0,70 EUR 0,72%

142,25 EUR 0,10 EUR 0,07%

Indizes

PKT PKT

PKT PKT

1.657,3 PKT -4,9 PKT -0,29%

19.261,8 PKT -34,2 PKT -0,18%

7.399,8 PKT -13,2 PKT -0,18%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

181,8 PKT 0,2 PKT 0,10%

44.733,9 PKT -126,4 PKT -0,28%

492,5 PKT -2,3 PKT -0,47%

10.134,1 PKT -11,7 PKT -0,11%

19.265,0 PKT -57,0 PKT -0,30%

19.246,9 PKT -58,2 PKT -0,30%

17.219,6 PKT 134,7 PKT 0,79%

7.505,0 PKT -12,6 PKT -0,17%

15.716,6 PKT -0,9 PKT -0,01%

2.883,3 PKT -11,7 PKT -0,40%

5.999,5 PKT -22,2 PKT -0,37%

19.270,9 PKT -52,7 PKT -0,27%

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One stock to keep an eye on is Merck KGaA (MKKGY). MKKGY is currently sporting a Zacks Rank of #2 (Buy) and an A for Value.MKKGY is also sporting a PEG ratio of 2.13. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. MKKGY's PEG compares to its industry's average PEG of 2.25. MKKGY's PEG has been as high as 2.31 and as low as 2.07, with a median of 2.20, all within the past year.Investors should also recognize that MKKGY has a P/B ratio of 0.63. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. This stock's P/B looks attractive against its industry's average P/B of 1.38. Over the past year, MKKGY's P/B has been as high as 0.84 and as low as 0.61, with a median of 0.73.Finally, investors will want to recognize that MKKGY has a P/CF ratio of 7.57. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. MKKGY's P/CF compares to its industry's average P/CF of 9.23. Over the past year, MKKGY's P/CF has been as high as 17.18 and as low as 7.35, with a median of 14.31.Value investors will likely look at more than just these metrics, but the above data helps show that Merck KGaA is likely undervalued currently. And when considering the strength of its earnings outlook, MKKGY sticks out at as one of the market's strongest value stocks.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck KGaA (MKKGY): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Merck

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Merck

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Merck KGaA

Analysen zu Merck KGaA

DatumRatingAnalyst
18.11.2024Merck OverweightJP Morgan Chase & Co.
15.11.2024Merck BuyDeutsche Bank AG
15.11.2024Merck BuyUBS AG
15.11.2024Merck BuyGoldman Sachs Group Inc.
14.11.2024Merck BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
18.11.2024Merck OverweightJP Morgan Chase & Co.
15.11.2024Merck BuyDeutsche Bank AG
15.11.2024Merck BuyUBS AG
15.11.2024Merck BuyGoldman Sachs Group Inc.
14.11.2024Merck BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
18.10.2024Merck Market-PerformBernstein Research
29.07.2024Merck Market-PerformBernstein Research
25.06.2024Merck Market-PerformBernstein Research
06.12.2023Merck HaltenDZ BANK
27.11.2023Merck HaltenDZ BANK
DatumRatingAnalyst
06.03.2023Merck VerkaufenDZ BANK
02.03.2023Merck SellGoldman Sachs Group Inc.
07.02.2023Merck SellGoldman Sachs Group Inc.
02.02.2023Merck VerkaufenDZ BANK
15.11.2022Merck SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Merck KGaA nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"